Raiffeisen Bank International AG Has $5.33 Million Stake in Option Care Health, Inc. $OPCH

Raiffeisen Bank International AG boosted its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 92.3% during the 2nd quarter, HoldingsChannel reports. The fund owned 250,000 shares of the company’s stock after acquiring an additional 120,000 shares during the quarter. Raiffeisen Bank International AG’s holdings in Option Care Health were worth $5,330,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the stock. McIlrath & Eck LLC acquired a new position in Option Care Health in the 2nd quarter worth $37,000. Advisory Services Network LLC acquired a new stake in shares of Option Care Health in the 3rd quarter valued at about $35,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Option Care Health in the 3rd quarter valued at about $38,000. Employees Retirement System of Texas bought a new stake in shares of Option Care Health in the fourth quarter valued at about $45,000. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Option Care Health by 528.1% in the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after purchasing an additional 1,183 shares in the last quarter. 98.05% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on OPCH shares. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $24.00 price objective (down from $26.00) on shares of Option Care Health in a research report on Thursday, July 30th. UBS Group restated a “buy” rating on shares of Option Care Health in a research note on Tuesday, June 16th. Zacks Research raised Option Care Health from a “strong sell” rating to a “hold” rating in a research report on Monday, July 6th. The Goldman Sachs Group began coverage on shares of Option Care Health in a research note on Monday, June 8th. They set a “neutral” rating and a $22.00 price target for the company. Finally, Stephens reiterated an “equal weight” rating and issued a $24.00 price objective (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Option Care Health has an average rating of “Hold” and a consensus target price of $29.92.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $24.21 on Friday. The stock has a market capitalization of $3.63 billion, a price-to-earnings ratio of 18.20, a PEG ratio of 1.42 and a beta of 0.61. The business has a 50-day moving average of $22.80 and a 200-day moving average of $24.86. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98. Option Care Health, Inc. has a fifty-two week low of $18.01 and a fifty-two week high of $36.80.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The business had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same quarter in the previous year, the business earned $0.41 earnings per share. Option Care Health’s quarterly revenue was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. As a group, sell-side analysts predict that Option Care Health, Inc. will post 1.69 earnings per share for the current fiscal year.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.